Literature DB >> 16325574

A genomic and functional inventory of deubiquitinating enzymes.

Sebastian M B Nijman1, Mark P A Luna-Vargas, Arno Velds, Thijn R Brummelkamp, Annette M G Dirac, Titia K Sixma, René Bernards.   

Abstract

Posttranslational modification of proteins by the small molecule ubiquitin is a key regulatory event, and the enzymes catalyzing these modifications have been the focus of many studies. Deubiquitinating enzymes, which mediate the removal and processing of ubiquitin, may be functionally as important but are less well understood. Here, we present an inventory of the deubiquitinating enzymes encoded in the human genome. In addition, we review the literature concerning these enzymes, with particular emphasis on their function, specificity, and the regulation of their activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325574     DOI: 10.1016/j.cell.2005.11.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  766 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.

Authors:  Daniela Flügel; Agnes Görlach; Thomas Kietzmann
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

3.  The deubiquitinating enzyme USP-46 negatively regulates the degradation of glutamate receptors to control their abundance in the ventral nerve cord of Caenorhabditis elegans.

Authors:  Jennifer R Kowalski; Caroline L Dahlberg; Peter Juo
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

4.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 5.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

7.  The Anaphase-Promoting Complex (APC) ubiquitin ligase regulates GABA transmission at the C. elegans neuromuscular junction.

Authors:  Jennifer R Kowalski; Hitesh Dube; Denis Touroutine; Kristen M Rush; Patricia R Goodwin; Marc Carozza; Zachary Didier; Michael M Francis; Peter Juo
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

8.  USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I.

Authors:  Lijuan Wang; Wei Zhao; Meng Zhang; Peng Wang; Kai Zhao; Xueying Zhao; Shangru Yang; Chengjiang Gao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 10.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.